Learn about Our Chapter & Our Mission -to cure and treat ALS and to provide compassionate support to all affected by it. Upcoming Special Events November 11th Veteran's Day Help our Veterans by sending a Letter to the Editor today! November 16th Candlelight Vigil     What a success! Walk the Extra Mile! Bay Area Walk to Defeat ALS   South Bay Walk to Defeat ALS   Ride the Extra Mile! Wine Country Ride to Defeat ALS The Sierra Challenge  Ride to Defeat ALS     Mind Based Stress Reduction Painting by Mike Bougher, Person with ALS Find out more about how you can be a part of an exciting new online program, which is open to people with ALS, families, caregivers, friends, and healthcare providers.   A new way to help The Greater Bay Area Chapter and help the environment The Greater Bay Area Chapter serves 24 Counties in Northern California   Find your Care Manager and Support Groups Find your Local  ALSA Certified Center Local opportunities for Clinical Trials   Gifts to Fight ALS- A Heart of Hope Bracelet Same Day eCard Available! Never Give Up Wine From Award-Winning Windsor Vineyards   The Batting 1000 Club Set up to the plate! Learn more about how you can become a member      Find out more about how YOU can participate in this exciting public awareness campaign! I am Lou-  My name is Leo White   We are Lou-  Meet the members of Dallas Ranch Middle School and Golden Hills Community Church From The Greater Bay Area Chapter Our Fall 2008 Newsletter is now available online! Our September eNewsletter is available for download! In Local News The Greater Bay Area Chapter's own Matt Chaney ! - 12/26/07- Lamorinda Weekly "The Naming of Chaney Field" - From KQED/Quest   "Emotions from the Inside Out"   In National News From ABC News.Com Life and Death: Mother Copes With Disclosing her Illness From Web MD Angela Landsbury talks about ALS       Disappointing Results from IGF-1 Clinical Trial  By Richard Robinson, Science Writer Subcutaneous (under the skin) delivery of insulin-like growth factor 1 (IGF-1), does not benefit people with ALS at a dose of 0.5 milligrams per kilogram of body weight, according to a large clinical trial whose results were released today. IGF-1 is a substance the body produces to sustain motor neurons, the nerve cells that die in ALS. Experiments in animal models of the disease suggested IGF-1 treatment may delay death of motor neurons. IGF-1 was tested in ALS a decade ago in two trials, but the results of the two were inconsistent, with one suggesting treatment was beneficial, and the other showing no benefit. “These results are deeply disappointing to all of us in the ALS community,” said Lucie Bruijn, Ph.D., senior vice president, research and development, The ALS Association. “The subcutaneous delivery route may be the key problem, or it may be that IGF-1 alone is not sufficient to rescue motor neurons.”   Read full story

Gifts to Help Fight ALS